| No. |
KEGG PATHWAY * On map, Yellow: Drug target, Red: Disease-related |
KEGG GENES * [Number of genes] |
KEGG DRUG * |
DrugBank |
Disease ID * [Number of diseases] |
| 1 | African trypanosomiasis 1 gene, 2 drugs (DrugBank), 10 diseases shown |
[1] IL1B |
D09315 |
Canakinumab |
[9] 46, 56, 84, 106, 107, 108, 113, 266, 269 |
| D06635 |
Rilonacept |
[4] 51, 106, 107, 266 |
| 2 | AGE-RAGE signaling pathway in diabetic complications 2 genes, 2 drugs (DrugBank), 10 diseases shown |
[2] IL1A, IL1B |
D06635 |
Rilonacept |
[4] 51, 106, 107, 266 |
| [1] IL1B |
D09315 |
Canakinumab |
[9] 46, 56, 84, 106, 107, 108, 113, 266, 269 |
| 3 | Alzheimer disease 1 gene, 2 drugs (DrugBank), 10 diseases shown |
[1] IL1B |
D09315 |
Canakinumab |
[9] 46, 56, 84, 106, 107, 108, 113, 266, 269 |
| D06635 |
Rilonacept |
[4] 51, 106, 107, 266 |
| 4 | Amoebiasis 3 genes, 3 drugs (DrugBank), 21 diseases shown |
[1] IL1B |
D09315 |
Canakinumab |
[9] 46, 56, 84, 106, 107, 108, 113, 266, 269 |
| D06635 |
Rilonacept |
[4] 51, 106, 107, 266 |
| [2] IL1R1, IL1R2 |
D02934 |
Anakinra |
[17] 2, 13, 15, 19, 37, 41, 46, 49, 50, 56, 65, 84, 86, 106, 107, 266, 299 |
| 5 | Antifolate resistance 1 gene, 2 drugs (DrugBank), 10 diseases shown |
[1] IL1B |
D09315 |
Canakinumab |
[9] 46, 56, 84, 106, 107, 108, 113, 266, 269 |
| D06635 |
Rilonacept |
[4] 51, 106, 107, 266 |
| 6 | C-type lectin receptor signaling pathway 1 gene, 2 drugs (DrugBank), 10 diseases shown |
[1] IL1B |
D09315 |
Canakinumab |
[9] 46, 56, 84, 106, 107, 108, 113, 266, 269 |
| D06635 |
Rilonacept |
[4] 51, 106, 107, 266 |
| 7 | Cellular senescence 1 gene, 1 drug (DrugBank), 4 diseases shown |
[1] IL1A |
D06635 |
Rilonacept |
[4] 51, 106, 107, 266 |
| 8 | Chagas disease (American trypanosomiasis) 1 gene, 2 drugs (DrugBank), 10 diseases shown |
[1] IL1B |
D09315 |
Canakinumab |
[9] 46, 56, 84, 106, 107, 108, 113, 266, 269 |
| D06635 |
Rilonacept |
[4] 51, 106, 107, 266 |
| 9 | Cytokine-cytokine receptor interaction 4 genes, 3 drugs (DrugBank), 21 diseases shown |
[2] IL1A, IL1B |
D06635 |
Rilonacept |
[4] 51, 106, 107, 266 |
| [1] IL1B |
D09315 |
Canakinumab |
[9] 46, 56, 84, 106, 107, 108, 113, 266, 269 |
| [2] IL1R1, IL1R2 |
D02934 |
Anakinra |
[17] 2, 13, 15, 19, 37, 41, 46, 49, 50, 56, 65, 84, 86, 106, 107, 266, 299 |
| 10 | Cytosolic DNA-sensing pathway 1 gene, 2 drugs (DrugBank), 10 diseases shown |
[1] IL1B |
D09315 |
Canakinumab |
[9] 46, 56, 84, 106, 107, 108, 113, 266, 269 |
| D06635 |
Rilonacept |
[4] 51, 106, 107, 266 |
| 11 | Fluid shear stress and atherosclerosis 4 genes, 3 drugs (DrugBank), 21 diseases shown |
[2] IL1A, IL1B |
D06635 |
Rilonacept |
[4] 51, 106, 107, 266 |
| [1] IL1B |
D09315 |
Canakinumab |
[9] 46, 56, 84, 106, 107, 108, 113, 266, 269 |
| [2] IL1R1, IL1R2 |
D02934 |
Anakinra |
[17] 2, 13, 15, 19, 37, 41, 46, 49, 50, 56, 65, 84, 86, 106, 107, 266, 299 |
| 12 | Graft-versus-host disease 2 genes, 2 drugs (DrugBank), 10 diseases shown |
[2] IL1A, IL1B |
D06635 |
Rilonacept |
[4] 51, 106, 107, 266 |
| [1] IL1B |
D09315 |
Canakinumab |
[9] 46, 56, 84, 106, 107, 108, 113, 266, 269 |
| 13 | Hematopoietic cell lineage 4 genes, 3 drugs (DrugBank), 21 diseases shown |
[2] IL1A, IL1B |
D06635 |
Rilonacept |
[4] 51, 106, 107, 266 |
| [1] IL1B |
D09315 |
Canakinumab |
[9] 46, 56, 84, 106, 107, 108, 113, 266, 269 |
| [2] IL1R1, IL1R2 |
D02934 |
Anakinra |
[17] 2, 13, 15, 19, 37, 41, 46, 49, 50, 56, 65, 84, 86, 106, 107, 266, 299 |
| 14 | Herpes simplex virus 1 infection 1 gene, 2 drugs (DrugBank), 10 diseases shown |
[1] IL1B |
D09315 |
Canakinumab |
[9] 46, 56, 84, 106, 107, 108, 113, 266, 269 |
| D06635 |
Rilonacept |
[4] 51, 106, 107, 266 |
| 15 | Human cytomegalovirus infection 2 genes, 3 drugs (DrugBank), 21 diseases shown |
[1] IL1B |
D09315 |
Canakinumab |
[9] 46, 56, 84, 106, 107, 108, 113, 266, 269 |
| D06635 |
Rilonacept |
[4] 51, 106, 107, 266 |
| [1] IL1R1 |
D02934 |
Anakinra |
[17] 2, 13, 15, 19, 37, 41, 46, 49, 50, 56, 65, 84, 86, 106, 107, 266, 299 |
| 16 | Human T-cell leukemia virus 1 infection 2 genes, 1 drug (DrugBank), 17 diseases shown |
[2] IL1R1, IL1R2 |
D02934 |
Anakinra |
[17] 2, 13, 15, 19, 37, 41, 46, 49, 50, 56, 65, 84, 86, 106, 107, 266, 299 |
| 17 | IL-17 signaling pathway 1 gene, 2 drugs (DrugBank), 10 diseases shown |
[1] IL1B |
D09315 |
Canakinumab |
[9] 46, 56, 84, 106, 107, 108, 113, 266, 269 |
| D06635 |
Rilonacept |
[4] 51, 106, 107, 266 |
| 18 | Inflammatory bowel disease (IBD) 2 genes, 2 drugs (DrugBank), 10 diseases shown |
[2] IL1A, IL1B |
D06635 |
Rilonacept |
[4] 51, 106, 107, 266 |
| [1] IL1B |
D09315 |
Canakinumab |
[9] 46, 56, 84, 106, 107, 108, 113, 266, 269 |
| 19 | Inflammatory mediator regulation of TRP channels 2 genes, 3 drugs (DrugBank), 21 diseases shown |
[1] IL1B |
D09315 |
Canakinumab |
[9] 46, 56, 84, 106, 107, 108, 113, 266, 269 |
| D06635 |
Rilonacept |
[4] 51, 106, 107, 266 |
| [1] IL1R1 |
D02934 |
Anakinra |
[17] 2, 13, 15, 19, 37, 41, 46, 49, 50, 56, 65, 84, 86, 106, 107, 266, 299 |
| 20 | Influenza A 2 genes, 2 drugs (DrugBank), 10 diseases shown |
[2] IL1A, IL1B |
D06635 |
Rilonacept |
[4] 51, 106, 107, 266 |
| [1] IL1B |
D09315 |
Canakinumab |
[9] 46, 56, 84, 106, 107, 108, 113, 266, 269 |
| 21 | Legionellosis 1 gene, 2 drugs (DrugBank), 10 diseases shown |
[1] IL1B |
D09315 |
Canakinumab |
[9] 46, 56, 84, 106, 107, 108, 113, 266, 269 |
| D06635 |
Rilonacept |
[4] 51, 106, 107, 266 |
| 22 | Leishmaniasis 2 genes, 2 drugs (DrugBank), 10 diseases shown |
[2] IL1A, IL1B |
D06635 |
Rilonacept |
[4] 51, 106, 107, 266 |
| [1] IL1B |
D09315 |
Canakinumab |
[9] 46, 56, 84, 106, 107, 108, 113, 266, 269 |
| 23 | Malaria 1 gene, 2 drugs (DrugBank), 10 diseases shown |
[1] IL1B |
D09315 |
Canakinumab |
[9] 46, 56, 84, 106, 107, 108, 113, 266, 269 |
| D06635 |
Rilonacept |
[4] 51, 106, 107, 266 |
| 24 | MAPK signaling pathway 3 genes, 3 drugs (DrugBank), 21 diseases shown |
[2] IL1A, IL1B |
D06635 |
Rilonacept |
[4] 51, 106, 107, 266 |
| [1] IL1B |
D09315 |
Canakinumab |
[9] 46, 56, 84, 106, 107, 108, 113, 266, 269 |
| [1] IL1R1 |
D02934 |
Anakinra |
[17] 2, 13, 15, 19, 37, 41, 46, 49, 50, 56, 65, 84, 86, 106, 107, 266, 299 |
| 25 | Measles 2 genes, 2 drugs (DrugBank), 10 diseases shown |
[2] IL1A, IL1B |
D06635 |
Rilonacept |
[4] 51, 106, 107, 266 |
| [1] IL1B |
D09315 |
Canakinumab |
[9] 46, 56, 84, 106, 107, 108, 113, 266, 269 |
| 26 | Necroptosis 2 genes, 2 drugs (DrugBank), 10 diseases shown |
[2] IL1A, IL1B |
D06635 |
Rilonacept |
[4] 51, 106, 107, 266 |
| [1] IL1B |
D09315 |
Canakinumab |
[9] 46, 56, 84, 106, 107, 108, 113, 266, 269 |
| 27 | NF-kappa B signaling pathway 2 genes, 3 drugs (DrugBank), 21 diseases shown |
[1] IL1B |
D09315 |
Canakinumab |
[9] 46, 56, 84, 106, 107, 108, 113, 266, 269 |
| D06635 |
Rilonacept |
[4] 51, 106, 107, 266 |
| [1] IL1R1 |
D02934 |
Anakinra |
[17] 2, 13, 15, 19, 37, 41, 46, 49, 50, 56, 65, 84, 86, 106, 107, 266, 299 |
| 28 | NOD-like receptor signaling pathway 1 gene, 2 drugs (DrugBank), 10 diseases shown |
[1] IL1B |
D09315 |
Canakinumab |
[9] 46, 56, 84, 106, 107, 108, 113, 266, 269 |
| D06635 |
Rilonacept |
[4] 51, 106, 107, 266 |
| 29 | Non-alcoholic fatty liver disease (NAFLD) 2 genes, 2 drugs (DrugBank), 10 diseases shown |
[2] IL1A, IL1B |
D06635 |
Rilonacept |
[4] 51, 106, 107, 266 |
| [1] IL1B |
D09315 |
Canakinumab |
[9] 46, 56, 84, 106, 107, 108, 113, 266, 269 |
| 30 | Osteoclast differentiation 3 genes, 3 drugs (DrugBank), 21 diseases shown |
[2] IL1A, IL1B |
D06635 |
Rilonacept |
[4] 51, 106, 107, 266 |
| [1] IL1B |
D09315 |
Canakinumab |
[9] 46, 56, 84, 106, 107, 108, 113, 266, 269 |
| [1] IL1R1 |
D02934 |
Anakinra |
[17] 2, 13, 15, 19, 37, 41, 46, 49, 50, 56, 65, 84, 86, 106, 107, 266, 299 |
| 31 | Pathogenic Escherichia coli infection 2 genes, 3 drugs (DrugBank), 21 diseases shown |
[1] IL1B |
D09315 |
Canakinumab |
[9] 46, 56, 84, 106, 107, 108, 113, 266, 269 |
| D06635 |
Rilonacept |
[4] 51, 106, 107, 266 |
| [1] IL1R1 |
D02934 |
Anakinra |
[17] 2, 13, 15, 19, 37, 41, 46, 49, 50, 56, 65, 84, 86, 106, 107, 266, 299 |
| 32 | Pertussis 2 genes, 2 drugs (DrugBank), 10 diseases shown |
[2] IL1A, IL1B |
D06635 |
Rilonacept |
[4] 51, 106, 107, 266 |
| [1] IL1B |
D09315 |
Canakinumab |
[9] 46, 56, 84, 106, 107, 108, 113, 266, 269 |
| 33 | Prion diseases 2 genes, 2 drugs (DrugBank), 10 diseases shown |
[2] IL1A, IL1B |
D06635 |
Rilonacept |
[4] 51, 106, 107, 266 |
| [1] IL1B |
D09315 |
Canakinumab |
[9] 46, 56, 84, 106, 107, 108, 113, 266, 269 |
| 34 | Prostate cancer 1 gene, 1 drug (DrugBank), 17 diseases shown |
[1] IL1R2 |
D02934 |
Anakinra |
[17] 2, 13, 15, 19, 37, 41, 46, 49, 50, 56, 65, 84, 86, 106, 107, 266, 299 |
| 35 | Rheumatoid arthritis 2 genes, 2 drugs (DrugBank), 10 diseases shown |
[2] IL1A, IL1B |
D06635 |
Rilonacept |
[4] 51, 106, 107, 266 |
| [1] IL1B |
D09315 |
Canakinumab |
[9] 46, 56, 84, 106, 107, 108, 113, 266, 269 |
| 36 | Salmonella infection 2 genes, 2 drugs (DrugBank), 10 diseases shown |
[2] IL1A, IL1B |
D06635 |
Rilonacept |
[4] 51, 106, 107, 266 |
| [1] IL1B |
D09315 |
Canakinumab |
[9] 46, 56, 84, 106, 107, 108, 113, 266, 269 |
| 37 | Shigellosis 2 genes, 3 drugs (DrugBank), 21 diseases shown |
[1] IL1B |
D09315 |
Canakinumab |
[9] 46, 56, 84, 106, 107, 108, 113, 266, 269 |
| D06635 |
Rilonacept |
[4] 51, 106, 107, 266 |
| [1] IL1R1 |
D02934 |
Anakinra |
[17] 2, 13, 15, 19, 37, 41, 46, 49, 50, 56, 65, 84, 86, 106, 107, 266, 299 |
| 38 | Th17 cell differentiation 2 genes, 3 drugs (DrugBank), 21 diseases shown |
[1] IL1B |
D09315 |
Canakinumab |
[9] 46, 56, 84, 106, 107, 108, 113, 266, 269 |
| D06635 |
Rilonacept |
[4] 51, 106, 107, 266 |
| [1] IL1R1 |
D02934 |
Anakinra |
[17] 2, 13, 15, 19, 37, 41, 46, 49, 50, 56, 65, 84, 86, 106, 107, 266, 299 |
| 39 | TNF signaling pathway 1 gene, 2 drugs (DrugBank), 10 diseases shown |
[1] IL1B |
D09315 |
Canakinumab |
[9] 46, 56, 84, 106, 107, 108, 113, 266, 269 |
| D06635 |
Rilonacept |
[4] 51, 106, 107, 266 |
| 40 | Toll-like receptor signaling pathway 1 gene, 2 drugs (DrugBank), 10 diseases shown |
[1] IL1B |
D09315 |
Canakinumab |
[9] 46, 56, 84, 106, 107, 108, 113, 266, 269 |
| D06635 |
Rilonacept |
[4] 51, 106, 107, 266 |
| 41 | Transcriptional misregulation in cancer 1 gene, 1 drug (DrugBank), 17 diseases shown |
[1] IL1R2 |
D02934 |
Anakinra |
[17] 2, 13, 15, 19, 37, 41, 46, 49, 50, 56, 65, 84, 86, 106, 107, 266, 299 |
| 42 | Tuberculosis 2 genes, 2 drugs (DrugBank), 10 diseases shown |
[2] IL1A, IL1B |
D06635 |
Rilonacept |
[4] 51, 106, 107, 266 |
| [1] IL1B |
D09315 |
Canakinumab |
[9] 46, 56, 84, 106, 107, 108, 113, 266, 269 |
| 43 | Type I diabetes mellitus 2 genes, 2 drugs (DrugBank), 10 diseases shown |
[2] IL1A, IL1B |
D06635 |
Rilonacept |
[4] 51, 106, 107, 266 |
| [1] IL1B |
D09315 |
Canakinumab |
[9] 46, 56, 84, 106, 107, 108, 113, 266, 269 |
| 44 | Yersinia infection 1 gene, 2 drugs (DrugBank), 10 diseases shown |
[1] IL1B |
D09315 |
Canakinumab |
[9] 46, 56, 84, 106, 107, 108, 113, 266, 269 |
| D06635 |
Rilonacept |
[4] 51, 106, 107, 266 |